Matches in SemOpenAlex for { <https://semopenalex.org/work/W4231576061> ?p ?o ?g. }
- W4231576061 endingPage "1965" @default.
- W4231576061 startingPage "1965" @default.
- W4231576061 abstract "Colorectal cancer is the third leading cause of cancer death for both men and women, with an estimated 52 980 persons in the US projected to die of colorectal cancer in 2021. Colorectal cancer is most frequently diagnosed among persons aged 65 to 74 years. It is estimated that 10.5% of new colorectal cancer cases occur in persons younger than 50 years. Incidence of colorectal cancer (specifically adenocarcinoma) in adults aged 40 to 49 years has increased by almost 15% from 2000-2002 to 2014-2016. In 2016, 26% of eligible adults in the US had never been screened for colorectal cancer and in 2018, 31% were not up to date with screening.To update its 2016 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for colorectal cancer in adults 40 years or older. The review also examined whether these findings varied by age, sex, or race/ethnicity. In addition, as in 2016, the USPSTF commissioned a report from the Cancer Intervention and Surveillance Modeling Network Colorectal Cancer Working Group to provide information from comparative modeling on how estimated life-years gained, colorectal cancer cases averted, and colorectal cancer deaths averted vary by different starting and stopping ages for various screening strategies.Asymptomatic adults 45 years or older at average risk of colorectal cancer (ie, no prior diagnosis of colorectal cancer, adenomatous polyps, or inflammatory bowel disease; no personal diagnosis or family history of known genetic disorders that predispose them to a high lifetime risk of colorectal cancer [such as Lynch syndrome or familial adenomatous polyposis]).The USPSTF concludes with high certainty that screening for colorectal cancer in adults aged 50 to 75 years has substantial net benefit. The USPSTF concludes with moderate certainty that screening for colorectal cancer in adults aged 45 to 49 years has moderate net benefit. The USPSTF concludes with moderate certainty that screening for colorectal cancer in adults aged 76 to 85 years who have been previously screened has small net benefit. Adults who have never been screened for colorectal cancer are more likely to benefit.The USPSTF recommends screening for colorectal cancer in all adults aged 50 to 75 years. (A recommendation) The USPSTF recommends screening for colorectal cancer in adults aged 45 to 49 years. (B recommendation) The USPSTF recommends that clinicians selectively offer screening for colorectal cancer in adults aged 76 to 85 years. Evidence indicates that the net benefit of screening all persons in this age group is small. In determining whether this service is appropriate in individual cases, patients and clinicians should consider the patient's overall health, prior screening history, and preferences. (C recommendation)." @default.
- W4231576061 created "2022-05-12" @default.
- W4231576061 creator A5001697819 @default.
- W4231576061 creator A5004784949 @default.
- W4231576061 creator A5006906657 @default.
- W4231576061 creator A5015392464 @default.
- W4231576061 creator A5017354513 @default.
- W4231576061 creator A5027475930 @default.
- W4231576061 creator A5030796795 @default.
- W4231576061 creator A5036385583 @default.
- W4231576061 creator A5041724803 @default.
- W4231576061 creator A5042231372 @default.
- W4231576061 creator A5043684489 @default.
- W4231576061 creator A5046391633 @default.
- W4231576061 creator A5046810568 @default.
- W4231576061 creator A5050331319 @default.
- W4231576061 creator A5061848647 @default.
- W4231576061 creator A5061952939 @default.
- W4231576061 creator A5086871945 @default.
- W4231576061 creator A5088060708 @default.
- W4231576061 date "2021-05-18" @default.
- W4231576061 modified "2023-10-18" @default.
- W4231576061 title "Screening for Colorectal Cancer" @default.
- W4231576061 cites W1976168468 @default.
- W4231576061 cites W2073314329 @default.
- W4231576061 cites W2073446948 @default.
- W4231576061 cites W2099828433 @default.
- W4231576061 cites W2106655865 @default.
- W4231576061 cites W2143929290 @default.
- W4231576061 cites W2159609271 @default.
- W4231576061 cites W2331422116 @default.
- W4231576061 cites W2341063738 @default.
- W4231576061 cites W2524309253 @default.
- W4231576061 cites W2592701528 @default.
- W4231576061 cites W2594373254 @default.
- W4231576061 cites W2622694076 @default.
- W4231576061 cites W2805885226 @default.
- W4231576061 cites W2890089597 @default.
- W4231576061 cites W2902995069 @default.
- W4231576061 cites W2983879469 @default.
- W4231576061 cites W3010729394 @default.
- W4231576061 cites W3097429569 @default.
- W4231576061 cites W3112517629 @default.
- W4231576061 cites W3134856831 @default.
- W4231576061 cites W3162019711 @default.
- W4231576061 cites W4211189475 @default.
- W4231576061 cites W4234608211 @default.
- W4231576061 cites W4237720803 @default.
- W4231576061 cites W4237938703 @default.
- W4231576061 cites W4239833184 @default.
- W4231576061 doi "https://doi.org/10.1001/jama.2021.6238" @default.
- W4231576061 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34003218" @default.
- W4231576061 hasPublicationYear "2021" @default.
- W4231576061 type Work @default.
- W4231576061 citedByCount "605" @default.
- W4231576061 countsByYear W42315760612020 @default.
- W4231576061 countsByYear W42315760612021 @default.
- W4231576061 countsByYear W42315760612022 @default.
- W4231576061 countsByYear W42315760612023 @default.
- W4231576061 crossrefType "journal-article" @default.
- W4231576061 hasAuthorship W4231576061A5001697819 @default.
- W4231576061 hasAuthorship W4231576061A5004784949 @default.
- W4231576061 hasAuthorship W4231576061A5006906657 @default.
- W4231576061 hasAuthorship W4231576061A5015392464 @default.
- W4231576061 hasAuthorship W4231576061A5017354513 @default.
- W4231576061 hasAuthorship W4231576061A5027475930 @default.
- W4231576061 hasAuthorship W4231576061A5030796795 @default.
- W4231576061 hasAuthorship W4231576061A5036385583 @default.
- W4231576061 hasAuthorship W4231576061A5041724803 @default.
- W4231576061 hasAuthorship W4231576061A5042231372 @default.
- W4231576061 hasAuthorship W4231576061A5043684489 @default.
- W4231576061 hasAuthorship W4231576061A5046391633 @default.
- W4231576061 hasAuthorship W4231576061A5046810568 @default.
- W4231576061 hasAuthorship W4231576061A5050331319 @default.
- W4231576061 hasAuthorship W4231576061A5061848647 @default.
- W4231576061 hasAuthorship W4231576061A5061952939 @default.
- W4231576061 hasAuthorship W4231576061A5086871945 @default.
- W4231576061 hasAuthorship W4231576061A5088060708 @default.
- W4231576061 hasBestOaLocation W42315760611 @default.
- W4231576061 hasConcept C120665830 @default.
- W4231576061 hasConcept C121332964 @default.
- W4231576061 hasConcept C121608353 @default.
- W4231576061 hasConcept C126322002 @default.
- W4231576061 hasConcept C138816342 @default.
- W4231576061 hasConcept C142724271 @default.
- W4231576061 hasConcept C143998085 @default.
- W4231576061 hasConcept C2777910003 @default.
- W4231576061 hasConcept C2779134260 @default.
- W4231576061 hasConcept C2781179581 @default.
- W4231576061 hasConcept C52207206 @default.
- W4231576061 hasConcept C526805850 @default.
- W4231576061 hasConcept C61511704 @default.
- W4231576061 hasConcept C71924100 @default.
- W4231576061 hasConceptScore W4231576061C120665830 @default.
- W4231576061 hasConceptScore W4231576061C121332964 @default.
- W4231576061 hasConceptScore W4231576061C121608353 @default.
- W4231576061 hasConceptScore W4231576061C126322002 @default.
- W4231576061 hasConceptScore W4231576061C138816342 @default.